No Benefit to Adding Chemotherapy in Older Adults With NSCLC No Benefit to Adding Chemotherapy in Older Adults With NSCLC

Adding chemotherapy to immunotherapy increased the adverse event burden without improving survival outcomes compared with immunotherapy alone in older adults with NSCLC.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news